Get started
Author

Carmella Angus

Observed names: C Angus, C. Angus
OpenAlex ID: A5086865751
Alterations in serum sodium in relation to atrial natriuretic factor and other neuroendocrine variables in experimental pacing-induced heart failure
1989 · Gordon W. Moe, Terrance P. Stopps, et al. · Journal of the American College of Cardiology · 117
PDF
Evaluation of indices of left ventricular contractility and relaxation in evolving canine experimental heart failure
1992 · G. W Moe, C. Angus, et al. · Cardiovascular Research · 45
Pathophysiological role of changing atrial size and pressure in modulation of atrial natriuretic factor during evolving experimental heart failure
1990 · G. W Moe, C. Angus, et al. · Cardiovascular Research · 41
Response of atrial natriuretic factor to acute and chronic increases of atrial pressures in experimental heart failure in dogs. Role of changes in heart rate, atrial dimension, and cardiac tissue concentration.
1991 · G W Moe, E A Grima, et al. · Circulation · 38
PDF
Quality of life and response of negative symptoms in schizophrenia to haloperidol and the atypical antipsychotic remoxipride. The Canadian Remoxipride Group.
1997 · A G Awad, Y D Lapierre, et al. · PubMed Central · 29
Efficacy of atorvastatin in achieving National Cholesterol Education Program low-density lipoprotein targets in women with severe dyslipidemia and cardiovascular disease or risk factors for cardiovascular disease: The Women’s Atorvastatin Trial on Cholesterol (WATCH)
2001 · Ruth McPherson, Carmella Angus, et al. · American Heart Journal · 22
The treatment of negative symptoms: a clinical and methodological study
1999 · Y D Lapierre, C Angus, et al. · International Clinical Psychopharmacology · 13
Remoxipride in the Treatment of Levodopa-Induced Psychosis
1996 · Paul Sandor, Anthony E. Lang, et al. · Journal of Clinical Psychopharmacology · 12
The women's atorvastatin trial on cholesterol (WATCH): Frequency of achieving NCEP-II target LDL-C levels in women with and without established CVD
1999 · R. Mcpherson, J. Genest, et al. · Atherosclerosis · 3
A Call to Participate in Prime Mentors International: Mentoring "At-Risk" Children
2016 · Carmella Angus · The Delta Kappa Gamma bulletin
The Can-ADA study: How does atorvastatin therapy impact on acheivement of NCEP-II lipid parameters in ischemic heart disease subjects with and without type 2 diabetes?
2000 · Lawrence A Leiter, Peter Bogary, et al. · Diabetes Research and Clinical Practice
Negative symptoms and quality of life in schizophrenia-response to low dose neuroleptic: Lessons from a clinical trial
1998 · A.G. Awad, Y.D. Lapierre, et al. · Schizophrenia Research
Works count: 12
Citation count: 320
H-index: 8
I10-index: 8
Year
Topic
Type